As of 2025-08-02, the Fair Value of Nymox Pharmaceutical Corp (NYMX) is -1.48 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.20 USD, the upside of Nymox Pharmaceutical Corp is -839.95%.
With the market price of 0.20 USD and our fair value calculation, Nymox Pharmaceutical Corp (NYMX) is not a good investment. Investing in NYMX stocks now will result in a potential loss of 839.95%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | - | - | 5Y Avg | |
| Net income | -12.54 | -6.58 | - | - | -9.56 | |
| YoY growth | -6.81% | 47.55% | - | - | 20.37% | |
| Market Cap (mil) | 18.10 |
| P/E | |
| Forward P/E |
| EPS | -0.07 |
| Avg earnings growth rate | 20.37% |
| TTM earnings | -6.58 |